Xela Domains Logo

RXLOBBYIST.COM

WELCOME TO RXLOBBYIST.COM

RXLOBBYIST.COM is singular-advocate English: Rx Lobbyist—one pharmacy policy advocate practice, one personal government-affairs desk, and one meet-your-Rx-Lobbyist funnel—not RxLobbyists.com plural firm directories.

Best-fit buyers: independent pharmacy lobbyists; solo government-affairs consultants; personal policy brands; defensive holders. Exact-fit launch: an Rx Lobbyist bio hub with issue tiles, briefing FAQ, and book-CTA.

OpenSecrets reports pharmaceuticals/health products spent more than $384.5 million on federal lobbying in 2024—the industry climate solo Rx lobbyists practice inside.[1] PhRMA alone booked $31.72 million in 2024 lobbying—illustrating the scale of pharmacy-policy advocacy spend.[2] That industry × association spine frames why exact RxLobbyist inventory matters—not an invented lobbying TAM.

Why Choose RXLOBBYIST.COM

BUY NOW - $38,480

Buy Now — RXLOBBYIST.COM. Own the rxlobbyist hostname.

MAKE AN OFFER

Purchase RXLOBBYIST.COM today through our trusted partners:

WHAT DOES ANTHONY IVERSONS THINK?

Anthony Iversons

"RxLobbyist.com is singular-advocate inventory—one Lobbyist hero, not the plural Lobbyists twin."

Anthony Iversons, Legal Advisor
Contact Anthony Iversons via Email

FAQs

Who buys RxLobbyist.com?

Independent pharmacy lobbyists, solo GA consultants, personal policy brands, defensive holders.

What figures are cited?

OpenSecrets: pharma/health >$384.5M (2024); PhRMA $31.72M.

Vs RxLobbyists.com?

Singular advocate vs plural firm roster—unique.

LDA registration included?

No—domain only; buyer owns compliance.

Contact Us

Feel free to reach out to explore the potentials of RXLOBBYIST.COM for your business. 📬

📧 Email: info@xeladomains.com
📞 Phone: (858) 429-9352

Social Networks

Follow us on LinkedIn and Instagram to stay updated on the latest trends and opportunities in domain investments.

Instagram | LinkedIn

REFERENCES

  1. OpenSecrets — pharmaceuticals/health products federal lobbying >$384.5M in 2024; industry top spender since 1999 (>$6.1B since 1999)
  2. OpenSecrets — Pharmaceutical Research & Manufacturers of America (PhRMA) federal lobbying $31.72M in 2024